# Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)

> **NCT01499043** · PHASE2 · TERMINATED · sponsor: **Daiichi Sankyo** · enrollment: 6 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** PLX3397

## Key facts

- **NCT ID:** NCT01499043
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05-25
- **Primary completion:** 2013-03-11
- **Final completion:** 2013-03-11
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Business decision.
- **Last updated:** 2020-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01499043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01499043, "Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01499043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*